ProgressImage ProgressImage
Symbiotec Pharmalab Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 544889 border-img ISIN Demat INE899I01028 border-img Book Value 195.23 border-img NSE Symbol SYMBIOTEC border-img Div & Yield % 0 border-img Market Cap (₹ Cr.) 8166.31 border-img P/E 52.39 border-img EPS 24.26 border-img Face Value 2
Mar 2025
(₹ Cr.)
Mar 2024
(₹ Cr.)
Mar 2023
(₹ Cr.)
Mar 2022
(₹ Cr.)
Mar 2021
(₹ Cr.)
Mar 2020
(₹ Cr.)
SOURCES OF FUNDS :       
Share Capital 10.9410.9410.9410.9410.9410.94
Reserves Total 899.85750.20661.88684.25622.42486.90
Equity Share Warrants 0.000.000.000.000.000.00
Equity Application Money 0.000.000.000.000.000.00
Total Shareholders Funds 910.79761.14672.82695.19633.36497.84
Secured Loans 292.5251.72107.2763.5947.42117.50
Unsecured Loans 0.000.000.000.000.003.19
Total Debt 292.5251.72107.2763.5947.42120.69
Other Liabilities 15.4112.367.136.675.995.30
Total Liabilities 1218.72825.22787.22765.45686.77623.83
APPLICATION OF FUNDS :       
Gross Block 544.84513.66418.24391.57348.52309.01
Less : Accumulated Depreciation 227.77189.84152.59125.49100.9479.40
Less:Impairment of Assets 0.000.000.000.000.000.00
Net Block 317.07323.82265.65266.08247.58229.61
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress 59.0519.3673.9022.6226.7330.50
Producing Properties 0.000.000.000.000.000.00
Investments 44.2042.2565.60130.17122.59110.39
Current Assets, Loans & Advances       
Inventories 254.03332.61241.72245.41225.26230.85
Sundry Debtors 175.98125.43112.31143.66118.69106.92
Cash and Bank Balance 22.596.272.836.3241.1428.54
Loans and Advances 26.6333.9829.7620.2426.9421.51
Total Current Assets 479.23498.29386.62415.62412.03387.82
Less : Current Liabilities and Provisions       
Current Liabilities 96.34244.86102.36103.36127.56126.64
Provisions 11.983.205.975.948.033.70
Total Current Liabilities & Provisions 108.32248.07108.33109.30135.59130.34
Net Current Assets 370.91250.23278.29306.32276.44257.48
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets 0.916.030.000.000.002.59
Deferred Tax Liability 21.9919.9419.5719.7519.5117.99
Net Deferred Tax -21.08-13.91-19.57-19.75-19.51-15.40
Other Assets 448.58203.47123.3559.9932.9511.24
Total Assets 1218.73825.22787.22765.43686.78623.82
Contingent Liabilities 0.000.000.710.000.000.87
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement   |    CDSL MyEasi   |    TRAI Notice on UCC   |    SEBI Risk Disclosure   |    Investor Notice

BSE Delayed data sourced at 5 minutes – www.bseindia.com | NSE Delayed data sourced at 15 minutes – www.nseindia.com

Disclaimer : Investment in securities market are subject to market risks, read all the related documents carefully before investing. Registration granted by SEBI, membership of RAASB and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

x
x
×
Let's Chat
imsl-img
close
refresh